Pfenniger Richard C.'s most recent trade in Opko Health Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opko Health Inc | Mr. Richard C. Pfenniger, Jr | Director | 18 Jun 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 18 Jun 2026 | 4,248 | 4,248 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 3,576 | 45,082 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 18 Jun 2026 | 3,576 | 0 | - | - | Restricted Stock Unit | ||
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger, Jr | Director | 09 Jan 2026 | 16,410 | 16,410 | - | - | Stock Options (Right to Buy) | ||
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger, Jr | Director | 28 Oct 2025 | 40,000 | 40,000 | - | - | Warrants | ||
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger, Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2025 | 20,000 | 31,400 (0%) | 0% | - | Common Stock | |
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger,Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2025 | 20,000 | 31,400 (0%) | 0% | - | - | |
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger,Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2025 | 20,000 | 31,400 (0%) | 0% | - | - | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 41,506 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 918 | 28,582 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 02 May 2025 | 918 | 0 | - | - | Restricted Stock Unit | ||
| Opko Health Inc | Mr. Richard C. Pfenniger, Jr | Director | 23 Apr 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger, Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 8,067 | 11,400 (0%) | 0% | - | Common Stock | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 27,664 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 02 May 2024 | 918 | 918 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 918 | 21,836 | - | 0 | Class A Common Stock | |
| Opko Health Inc | Mr. Richard C. Pfenniger, Jr | Director | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 05 Jan 2024 | 13,000 | 313,000 (0%) | 0% | 0.9 | 12,043 | Common Stock |
| Opko Health Inc | Mr. Richard C. Pfenniger, Jr | Director | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 05 Jan 2024 | 12,000 | 325,000 (0%) | 0% | 0.9 | 11,386 | Common Stock |
| Opko Health Inc | Mr. Richard C. Pfenniger,Jr | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 13 Nov 2023 | 10,000 | 300,000 (0%) | 0% | 1.3 | 12,999 | - |
| Opko Health Inc | Mr. Richard C. Pfenniger,Jr | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 13 Nov 2023 | 5,000 | 280,000 (0%) | 0% | 1.3 | 6,497 | - |
| Opko Health Inc | Mr. Richard C. Pfenniger,Jr | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 13 Nov 2023 | 5,000 | 285,000 (0%) | 0% | 1.3 | 6,497 | - |
| Opko Health Inc | Mr. Richard C. Pfenniger,Jr | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 13 Nov 2023 | 5,000 | 290,000 (0%) | 0% | 1.3 | 6,499 | - |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Purchase of securities on an exchange or from another person at price $ 1.49 per share. | 08 Nov 2023 | 10,000 | 20,918 | - | 1.5 | 14,889 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 17 Aug 2023 | 5,000 | 10,918 | - | 5.1 | 25,523 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | ||
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger,Jr | Director | 18 Jul 2023 | 7,333 | 7,333 | - | - | Stock Options (Right to Buy) | ||
| Opko Health Inc | Mr. Richard C. Pfenniger,Jr | Director | 22 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| Fluent Inc | Mr. Richard C. Pfenniger, Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 115,385 | 175,385 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Purchase of securities on an exchange or from another person at price $ 5.90 per share. | 18 May 2023 | 5,000 | 5,918 | - | 5.9 | 29,500 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | 02 May 2023 | 30,303 | 0 | - | - | Restricted Stock Unit | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 30,303 | 30,303 | - | 0 | Class A Common Stock | |
| Cocrystal Pharma Inc | Mr. Richard C. Pfenniger,Jr | Director | 25 Jul 2022 | 80,000 | 80,000 | - | - | Stock Options (Right to Buy) | ||
| Opko Health Inc | Mr. Richard C. Pfenniger,Jr | Director | 14 Jul 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
| GeneDx Holdings Corp (Class A) | Mr. Richard C. Pfenniger,Jr | Director | 02 May 2022 | 157,828 | 157,828 | - | - | Stock Option |